Evidence map›Paper›PMID 39257557›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)

Anti-epileptic drug use and subsequent degenerative dementia occurrence.

Naoki Ikegaya, Honoka Nakamura, Yutaro Takayama, Yohei Miyake, Takahiro Hayashi, Masaki Sonoda, Mitsuru Sato, Kensuke Tateishi, Jun Suenaga, Masao Takaishi and 8 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Naoki IkegayaYCU Epilepsy Center Yokohama City University Hospital Yokohama Japan.ORCID https://orcid.org/0000-0003-4439-3785
Honoka NakamuraSchool of Data Science Yokohama City University Yokohama Japan.
Yutaro TakayamaYCU Epilepsy Center Yokohama City University Hospital Yokohama Japan.
Yohei MiyakeDepartment of Neurosurgery Yokohama City University Graduate School of Medicine Yokohama Japan.
Takahiro HayashiYCU Epilepsy Center Yokohama City University Hospital Yokohama Japan.
Masaki SonodaYCU Epilepsy Center Yokohama City University Hospital Yokohama Japan.
Mitsuru SatoDepartment of Neurosurgery Yokohama City University Graduate School of Medicine Yokohama Japan.
Kensuke TateishiDepartment of Neurosurgery Yokohama City University Graduate School of Medicine Yokohama Japan.
Jun SuenagaDepartment of Neurosurgery Yokohama City University Graduate School of Medicine Yokohama Japan.
Masao TakaishiYCU Epilepsy Center Yokohama City University Hospital Yokohama Japan.
Yu KitazawaYCU Epilepsy Center Yokohama City University Hospital Yokohama Japan.
Misako KuniiYCU Epilepsy Center Yokohama City University Hospital Yokohama Japan.
Hiroki AbeDepartment of Physiology Yokohama City University Graduate School of Medicine Yokohama Japan.
Tomoyuki MiyazakiDepartment of Core Project Promotion, Center for Promotion of Research and Industry-Academic Collaboration Yokohama City University Yokohama Japan.
Tetsuaki AraiDepartment of Psychiatry Division of Clinical Medicine Institute of Medicine University of Tsukuba Tsukuba Japan.
Manabu IwasakiSchool of Data Science Yokohama City University Yokohama Japan.
Takayuki AbeSchool of Data Science Yokohama City University Yokohama Japan.
Tetsuya YamamotoYCU Epilepsy Center Yokohama City University Hospital Yokohama Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe use of anti-epileptic drugs (AEDs) in degenerative dementia (DD) remains uncertain. We aimed to evaluate the association of early AED administration with subsequent DD occurrence.

methodsUsing a large nationwide database, we enrolled patients newly diagnosed with epilepsy from 2014 to 2019 (

resultsOverall, 4489 pairs of patients (2156 women) were matched. The odds ratio (treatment/control) for DD occurrence was 0.533 (95% confidence interval: 0.459-0.617). The DD proportions significantly differed between the treatment (340/4489 = 0.076) and control (577/4489 = 0.129) groups. DISCUSSION: Among patients newly diagnosed with epilepsy, compared to non-use, early AED use was associated with a lower occurrence of subsequent DD. Further investigations into and optimization of early intervention for epilepsy in DD are warranted. Highlights: Anti-epileptic drug (AED) use before epilepsy diagnosis was linked with a lower subsequent degenerative dementia (DD) occurrence.Identifying the epileptic phenotype was crucial for justifying early AED use in DD.AED use with an epilepsy diagnosis did not pose an additional risk of DD.The potential contribution of combination drug therapy to the strategy was noted.

Indexed as

Alzheimer's diseaseanti‐epileptic drugdegenerative dementiaepilepsynationwide cohortneuronal hyperexcitability

Identifiers

PMID39257557
PMCPMC11386337

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.